A complete list of the members of the 409 Study Investigators appears in the Appendix S1.
Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma
Version of Record online: 13 MAR 2012
© 2012 Blackwell Publishing Ltd
British Journal of Haematology
Volume 157, Issue 4, pages 438–445, May 2012
How to Cite
Czuczman, M. S., Hess, G., Gadeberg, O. V., Pedersen, L. M., Goldstein, N., Gupta, I., Jewell, R. C., Lin, T. S., Lisby, S., Strange, C., Windfeld, K., Viardot, A. and for the 409 Study Investigators (2012), Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma. British Journal of Haematology, 157: 438–445. doi: 10.1111/j.1365-2141.2012.09086.x
- Issue online: 18 APR 2012
- Version of Record online: 13 MAR 2012
- Manuscript Accepted: 30 JAN 2012
- Manuscript Received: 2 NOV 2011
|bjh9086-sup-0001-Appendix1.doc||Word document||33K||Appendix S1. Hx-CD20-409 Study Group members.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.